MALAT1 and gestational diabetes: According to another study, lncRNA-MALAT1 expression levels were increased in the placentas of GDM patients, while siRNA intervention could inhibit inflammation development and trophoblast cell proliferation, invasion, and migration by downregulating lncRNA-MALAT1 expression, which may be achieved by regulating the TGF-β/ NF-κB signaling pathway [147].